Richard Rosenquist, MD
Pain Medicine · Cleveland, OHNPI 1598752826
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,076, 2.1 times the $524 reported in 2019.
Across 43 payments — averaging $97.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$751
- Saluda Medical Americas, Inc.$629
- Globus Medical$605
- Boston Scientific$372
- Vertos Medical, Inc.$327
- Stryker$316
- plus $1K from 11 others
Across 5 payments — averaging $280.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- MML US, Inc.$1K
- Saluda Medical Americas, Inc.$150
What the payments were for
- Grants$752%
- Food & beverage$4,13798%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 7 | $751 |
| Saluda Medical Americas, Inc. | 5 | $629 |
| Globus Medical | 5 | $605 |
| Boston Scientific | 5 | $372 |
| Vertos Medical, Inc. | 2 | $327 |
| Stryker | 2 | $316 |
| Abbott | 2 | $283 |
| Si-bone, Inc. | 2 | $182 |
| Siemens Medical Solutions USA, Inc. | 2 | $125 |
| Relievant Medsystems, Inc. | 1 | $108 |
| Captiva Spine Inc | 1 | $107 |
| MML US, Inc. | 1 | $103 |
| Medtronic(2 entities) | 2 | $102 |
| SPR Therapeutics, Inc | 3 | $86 |
| B. Braun Medical Inc. | 1 | $51 |
| Pacira Pharmaceuticals Incorporated | 1 | $32 |
| Heron Therapeutics, Inc. | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$700
- mild Device Kit$644
- Evoke$351
- Omnia$246
- GENERAL PAIN MANAGEMENT$214
- Evoke SCS$161
- Proclaim IPG$148
- PROCLAIM$135
- Superion Indirect Decompression System$128
- Senza Spinal Cord Stimulation System$124
- ELSA ATP$121
- Cios Fusion$112
- Intracept$108
- ECAP Study$107
- Transfasten$107
- ReActiv8$103
How this compares
$4,213 in reported general payments places this provider in the 60th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in Cleveland
- Nagy MekhailCleveland$511K
- Robert BolashCleveland$154K
- Aman UpadhyayCleveland$40K
- Salim HayekCleveland$34K
- Trishul KapoorCleveland$33K
- Edward CovingtonCleveland$25K
- Jianguo ChengCleveland$23K
- Kush GoyalCleveland$22K
- Jacob EzellCleveland$12K
- Jijun XuCleveland$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.